Extramedullary disease in multiple myeloma: a systematic literature review

by Beksac, M., Bladé, J., Caers, J., Jurczyszyn, A., Moreau, P., Rasche, L., Richardson, P., Rosiñol, L., Usmani, S.Z, von Lilienfeld-Toal, M., Zamagni, E.
Published 2022

Patient-reported outcomes in relapsed/refractory multiple myeloma treated with melflufen plus dexamethasone: analyses from the Phase II HORIZON study

by Alegre, A., Bakker, N.A, Bladé, J., Cavo, M., Larocca, A., Laubach, J., Leleu, X., Maisel, C., Mateos, M.-V, Mazumder, A., Nadeem, O., Oriol, A., Orre, M., Paner, A., Raptis, A., Richardson, P.G, Rodriguez-Otero, P., Sandberg, A., Torrång, A., Touzeau, C.
Published 2022

Unsupervised machine learning improves risk stratification in newly diagnosed multiple myeloma: an analysis of the Spanish Myeloma Group

by Bengoechea, E., Blade, J., Blanchard, M.J, Calasanz, M.J, de la Rubia, J., Diaz Arias, J., González Pérez, M.S, Granell, M., Gutierrez, N., Hernandez, M.T, Lahuerta, J.-J, López de la Guia, A., Martin, M.L, Martinez Lopez, J., Mateos, M.V, Mosquera Orgueira, A., Oriol, A., Palomera, L., PETHEMA/GEM Cooperative Group, Rios, R., Rosiñol, L., San Miguel, J., Sureda, A., Teruel, A.I
Published 2022

A simple score to predict early severe infections in patients with newly diagnosed multiple myeloma

by Alegre, A., Arguiñano, J.-M, Bargay, J., Bellón, J.-M, Bladé, J., Blanchard, M.-J, Cabrera, C., de Arriba, F., de la Guía, A.L, de la Rubia, J., Dourdil, V., Encinas, C., García, A., García-Mateo, A., García-Sanz, R., GEM/PETHEMA (Grupo Espanol de Mieloma/Programa para el Estudio de la Terapeutica en Hemopatias Malignas) cooperative study group, Gironella, M., Gonzalez, M.-S, Gonzalez, Y., Granell, M., Hernández, M.-T, Hernandez-Rivas, J., Iñigo, B., Jarque, I., Jímenez-Ubieto, A., Krsnik, I., Lahuerta, J.-J, Martín, J., Martínez-López, J., Mateos, M.-V, Ocio, E.M, Oriol, A., Pérez-Ávila, C.C, Rios, R., Rodríguez-Otero, P., Rosiñol, L., Sampol, A., San-Miguel, J.F, Silvent, M., Soler, J.-A, Sureda, A.
Published 2022